[
    {
        "question": "Dose of Nevirapine to Newborn for Prevention of Mother to child transmission of HIV is",
        "exp": "Bih Weight NVP daily dose(in mg) NVP daily dose(in ml) Duration Infants with bih weight <2000gm 2 mg/kg once daily 0. 2 ml/kg once daily Upto 6 weeks irrespective of exclusively breast fed or exclusive replacement fed Bih weight 2000 -2500gm 10 mg once daily 1 ml once daily Bih weight more than 2500gm 15 mg once daily 1. 5 ml once daily",
        "cop": 1,
        "opa": "2 mg/ kg",
        "opb": "5 mg/kg",
        "opc": "10 mg/kg",
        "opd": "20 mg/kg",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "NPCBVI, NACP",
        "id": "2337c6f6-f686-4ef2-b6fe-456df6c39e42",
        "choice_type": "single"
    },
    {
        "question": "Under the School vision screening programme, vision screening in schools is done by:",
        "exp": "Under school vision screening programme, Screening is done by class teacher 1 teacher per 150 students Visual acuity cut-off for referral- <6/9 - Comes under secondary level of prevention.",
        "cop": 4,
        "opa": "Ophthalmologist",
        "opb": "Optometrist",
        "opc": "NGO worker",
        "opd": "Teacher",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "NPCBVI, NACP",
        "id": "06aa3c0f-8771-44b4-9af1-2e498f375830",
        "choice_type": "single"
    },
    {
        "question": "Vision 2020 - The Right to Sight do not include:-",
        "exp": "VISION 2020: The Right to Sight- was launched in 1999 - Centres of excellence-20 - Training centres-200 - Service centres-2000 - Vision centres-20, 000 - Main aim of vision-2020 is to eliminate all causes of avoidable blindness, i. e Preventable blindness - Vit A deficiency, trachoma Curable blindness - cataract",
        "cop": 1,
        "opa": "Centres for Vision - 20",
        "opb": "Training Centres - 200",
        "opc": "Service Centres - 2000",
        "opd": "Vision Centres - 20, 000",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "NPCBVI, NACP",
        "id": "b857f14c-075c-48ce-82f2-0e143a6fff6c",
        "choice_type": "single"
    },
    {
        "question": "According to CDC recommendations, HIV screening of pregnant women is:-",
        "exp": "Opt-out testing: means performing an HIV test after notifying the patient that the test is normally performed, unless patient may elect to decline or defer testing. OPT-in testing: testing is offered and the patient is required to actively give permission before it can occur. WHO and CDC recommends opt-out testing policies in health care settings. Opt-out testing has a higher testing rate than opt-in testing. It does not eliminate the need for informed consent.",
        "cop": 2,
        "opa": "Opt-in testing",
        "opb": "Opt-out testing",
        "opc": "Compulsory",
        "opd": "Symptomatic",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "NPCBVI, NACP",
        "id": "abeec309-cbf0-4327-8c22-66fc1ef6b254",
        "choice_type": "single"
    },
    {
        "question": "For post-exposure prophylaxis of HIV is:-",
        "exp": "New post-exposure guidelines for HIV for adolescents and adults: Preferred backbone regimen: Tenofovir + Lamivudine for 4 weeks. Preferred third drug: Lopinavir / Ritonavir or Atazanavir / Ritonavir.",
        "cop": 1,
        "opa": "Tenoir + Lamivudine for 4 weeks",
        "opb": "Lamivudine + Ritonavir for 4 weeks",
        "opc": "Zidovudine + Lamivudine + Indinavir for 4 weeks",
        "opd": "Single dose Zidovudine + Lamivudine + Indinavir",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "NPCBVI, NACP",
        "id": "4fe877ed-648b-47fd-bb9d-36256df2a060",
        "choice_type": "single"
    },
    {
        "question": "SAFE strategy has been developed for the control of:-",
        "exp": "WHO has recommended 'SAFE strategy' for global elimination of trachoma:- Surgery. Antibiotic use. Facial cleanliness. Environmental improvement.",
        "cop": 2,
        "opa": "Onchocerciasis",
        "opb": "Trachoma",
        "opc": "Refractive error",
        "opd": "Ocular trauma",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "NPCBVI, NACP",
        "id": "5e17a040-563e-416a-9425-fddd8d2c1fa5",
        "choice_type": "single"
    },
    {
        "question": "CTL inducing vaccines, recombinant adeno-associated virus vaccine and modified vaccinia Ankara are being developed for:-",
        "exp": "CTL inducing vaccines, recombinant adeno-associated virus vaccine and modified vaccinia Ankara are being developed for HIV/AIDS. Since 1987, more than 30 HIV candidate vaccines have been tested in clinical trials phases I/II: some of them are: AIDS VAX; only vaccine in phase III trials. Cytotoxic T-Lymphocytes inducing vaccine. Recombinant adeno-associated virus vaccine. Modified vaccine Ankara vaccine. Subunit vaccine.",
        "cop": 4,
        "opa": "Tuberculosis",
        "opb": "Leprosy",
        "opc": "Malaria",
        "opd": "HIV/AIDS",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "NPCBVI, NACP",
        "id": "1bc024fc-b578-4dde-a1df-10663df327f3",
        "choice_type": "single"
    },
    {
        "question": "For diagnosis of HIV infection in asymptomatic, minimum number of tests required is/are:",
        "exp": "Screening of HIV: Strategy 1: one out of three screening tests are used; Done for screening every blood unit before transfusion. Strategy II: Two out of three screening tests are used; Done for screening person who is symptomatic with any one of AIDS defining illness. Strategy III: All three screening tests are used; Done for screening person who is asymptomatic.",
        "cop": 3,
        "opa": "1",
        "opb": "2",
        "opc": "3",
        "opd": "4",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "NPCBVI, NACP",
        "id": "50cf921f-21a2-4f82-8024-b9fa2730efd5",
        "choice_type": "single"
    }
]